ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $8,029,000 | -79.2% | 311,217 | -56.8% | 1.66% | -73.5% |
Q4 2020 | $38,518,000 | -51.4% | 720,502 | -62.5% | 6.26% | -12.3% |
Q3 2020 | $79,264,000 | -9.4% | 1,921,563 | +6.5% | 7.13% | +2.0% |
Q2 2020 | $87,488,000 | +3.8% | 1,804,993 | -9.6% | 6.99% | -20.6% |
Q1 2020 | $84,320,000 | +57.7% | 1,995,747 | +59.7% | 8.81% | +89.2% |
Q4 2019 | $53,475,000 | -32.2% | 1,250,000 | -42.9% | 4.66% | -35.7% |
Q3 2019 | $78,845,000 | -99.8% | 2,190,742 | +46.0% | 7.24% | +62.7% |
Q2 2019 | $40,095,000,000 | +74564.8% | 1,500,000 | -25.0% | 4.45% | -16.3% |
Q1 2019 | $53,700,000 | +20.7% | 2,000,000 | -27.3% | 5.32% | -5.5% |
Q4 2018 | $44,504,000 | +79.2% | 2,752,256 | +130.1% | 5.62% | +45.3% |
Q3 2018 | $24,831,000 | -18.7% | 1,196,098 | -40.2% | 3.87% | -8.6% |
Q2 2018 | $30,540,000 | +292.2% | 2,000,000 | +640.7% | 4.23% | +164.5% |
Q4 2016 | $7,787,000 | +178.5% | 270,000 | +170.0% | 1.60% | +59.5% |
Q1 2016 | $2,796,000 | – | 100,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |